The "brain-skin connection": Nerve growth factor-dependent pathways for stress-induced skin disorders

Journal of Molecular Medicine

Volumn 85, Issue 12, 2007, Pages 1347-1349

  Zoumakis, Emmanouil ^a   Kalantaridou, Sophia N ^b   Chrousos, George P ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b UNIVERSITY OF IOANNINA   (Greece)

Author keywords

CNS; CRF; Mast cells; NGF

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; NERVE GROWTH FACTOR; PEPTIDOLEUKOTRIENE; PROSTAGLANDIN D2; RECOMBINANT NERVE GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR; UROCORTIN; VASCULOTROPIN; VASOACTIVE INTESTINAL POLYPEPTIDE;

ACOUSTIC STRESS; ADRENERGIC SYSTEM; ARTICLE; BLOOD VESSEL PERMEABILITY; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNOCOMPETENT CELL; MAST CELL; MAST CELL DEGRANULATION; NERVE CELL; NERVE FIBER; NONHUMAN; SENSORY NERVE; SKIN DISEASE; SPINAL GANGLION; UPREGULATION;

ANIMALS; BRAIN; CALCITONIN GENE-RELATED PEPTIDE; DERMIS; DISEASE MODELS, ANIMAL; GANGLIA, SPINAL; HUMANS; INJECTIONS, INTRADERMAL; MICE; NERVE GROWTH FACTOR; NEURONAL PLASTICITY; NEUROPEPTIDES; NOISE; SIGNAL TRANSDUCTION; SKIN DISEASES; STRESS, PSYCHOLOGICAL; SUBSTANCE P; UP-REGULATION;

EID: 36849026650     PISSN: 09462716     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00109-007-0270-6     Document Type: Article

References (10)

1. Chrousos GP (1995) The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N Engl J Med 332:1351-1362
2. Elenkov IJ, Chrousos GP (2006) Stress system-organization, physiology and immunoregulation. Neuroimmunomodulation 13:257-267
3. Joachim RA, Kuhlmei A, Dinh QT, Handjiski B, Fischer T, Peters EM, Klapp BF, Paus R, Arck PC (2007) Neuronal plasticity of the "brain-skin- connection": stress-triggered up-regulation of neuropeptides in dorsal root ganglia and skin via nerve growth factor-dependent pathways. J Mol Med DOI 10.1007/s00109-007-0262-6
4. Kempuraj D, Papadopoulou NG, Lytinas M, Huang M, Kandere-Grzybowska K, Madhappan B, Boucher W, Christodoulou S, Athanassiou A, Theoharides TC (2004) Corticotropin-releasing hormone and its structurally related urocortin are synthesized and secreted by human mast cells. Endocrinology 145:43-48
5. Paus R, Theoharides TC, Arck PC (2006) Neuroimmunoendocrine circuitry of the 'brain-skin connection'. Trends Immunol 27:32-39
6. Pisarchik A, Slominski AT (2001) Alternative splicing of CRH-R1 receptors in human and mouse skin: identification of new variants and their differential expression. FASEB J 15:2754-2756
7. Schulte-Herbruggen O, Folster-Holst R, von Elstermann M, Augustin M, Hellweg R (2007) Clinical relevance of nerve growth factor serum levels in patients with atopic dermatitis and psoriasis. Int Arch Allergy Immunol 144:211-216
8. Theoharides TC, Singh LK, Boucher W, Pang X, Letourneau R, Webster E, Chrousos G (1998) Corticotropin-releasing hormone induces skin mast cell degranulation and increased vascular permeability, a possible explanation for its proinflammatory effects. Endocrinology 139:403-413
9. Theoharides TC, Spanos C, Pang X, Alferes L, Ligris K, Letourneau R, Rozniecki JJ, Webster E, Chrousos GP (1995) Stress-induced intracranial mast cell degranulation: a corticotropin-releasing hormone-mediated effect. Endocrinology 136:5745-5750
10. Zoumakis E, Rice KC, Gold PW, Chrousos GP (2006) Potential uses of corticotropin-releasing hormone antagonists. Ann N Y Acad Sci 1083:239-251